LONDON, May 30, 2024 /PRNewswire/ — Soterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its…
Moderate Alopecia AreataSoterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its randomised, placebo-controlled, multi-dose Phase II trial evaluating STS-01 as a treatment for mild / moderate AA. Once-daily topical treatment of mild / moderate alopecia areata (AA) .
Soterios: Topical STS-01 Hits Phase 2 Efficacy Endpoints for Mild to Moderate Alopecia hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.